Sale!

Hepatitis B Viral Drug Resistance and Genotyping Test Cost

Name: Hepatitis B Viral Drug Resistance and Genotyping Test Cost
SKU: TEST-4934
Price: 2340 AED
Availability: InStock

Original price was: 2,600 د.إ.Current price is: 2,340 د.إ.

-10%

Hepatitis B Viral Drug Resistance and Genotyping Test is a critical diagnostic tool used in the management and treatment of Hepatitis B virus (HBV) infections. This test is designed to identify mutations in the HBV genome that can lead to resistance against antiviral drugs. By understanding the genetic makeup of the virus, healthcare providers can tailor treatment plans to effectively combat the infection and reduce the risk of drug resistance. The genotyping aspect of the test further helps in determining the specific strain of HBV, which can influence the choice of treatment and provide insights into the prognosis of the infection.

The test is available at DNA Labs UAE, a leading facility known for its advanced diagnostic services. The cost of the Hepatitis B Viral Drug Resistance and Genotyping Test is set at 2340 AED. This investment is crucial for individuals diagnosed with HBV, as it guides the selection of the most effective therapeutic strategies, potentially leading to better health outcomes and minimizing the risk of liver disease progression.

Description

HEPATITIS B VIRAL DRUG RESISTANCE and GENOTYPING Test

Components: 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes. Separate plasma aseptically within 2 hours of collection. Ship refrigerated or frozen.

Price: 2340.0 AED

Report Delivery: Sample Daily by 11 am; Report 7 days

Method: Sequencing

Test type: Disorders of Liver

Doctor: Gastroenterologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: No special preparation required

Test Details:

Hepatitis B viral drug resistance testing is a diagnostic test that helps determine the effectiveness of antiviral medications in treating Hepatitis B infection. This test is particularly important in identifying drug-resistant strains of the virus, which can significantly impact treatment outcomes.

The Hepatitis B virus (HBV) can mutate over time, leading to the development of drug-resistant strains. These mutations can occur in the viral polymerase gene, which is the target of most antiviral medications used to treat Hepatitis B. Drug resistance can result in the virus replicating despite treatment, leading to ongoing liver damage and potential complications.

Genotyping is a technique used to identify the specific genetic makeup of the Hepatitis B virus. It involves analyzing the viral DNA sequence to determine its genotype or subtype. There are several genotypes of Hepatitis B, labeled as A to J, each with different geographic distributions and clinical implications.

Genotyping can provide valuable information about the progression and treatment of Hepatitis B infection. Certain genotypes may be associated with a higher risk of liver disease progression, increased transmission rates, or resistance to specific antiviral drugs. Additionally, genotyping can help guide treatment decisions by identifying which antiviral medications are likely to be most effective against a particular genotype.

In summary, Hepatitis B viral drug resistance and genotyping tests are essential tools in the management of Hepatitis B infection. These tests help healthcare providers tailor treatment plans to individual patients, ensuring the most effective and personalized care.

Test Name	HEPATITIS B VIRAL DRUG RESISTANCE and GENOTYPING Test
Components
Price	2340.0 AED
Sample Condition	3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes. Separate plasma aseptically within 2 hours of collection. Ship refrigerated or frozen.
Report Delivery	Sample Daily by 11 am; Report 7 days
Method	Sequencing
Test type	Disorders of Liver
Doctor	Gastroenterologist
Test Department:	MOLECULAR DIAGNOSTICS
Pre Test Information	No special preparation required
Test Details	Hepatitis B viral drug resistance testing is a diagnostic test that helps determine the effectiveness of antiviral medications in treating Hepatitis B infection. This test is particularly important in identifying drug-resistant strains of the virus, which can significantly impact treatment outcomes. The Hepatitis B virus (HBV) can mutate over time, leading to the development of drug-resistant strains. These mutations can occur in the viral polymerase gene, which is the target of most antiviral medications used to treat Hepatitis B. Drug resistance can result in the virus replicating despite treatment, leading to ongoing liver damage and potential complications. Genotyping is a technique used to identify the specific genetic makeup of the Hepatitis B virus. It involves analyzing the viral DNA sequence to determine its genotype or subtype. There are several genotypes of Hepatitis B, labeled as A to J, each with different geographic distributions and clinical implications. Genotyping can provide valuable information about the progression and treatment of Hepatitis B infection. Certain genotypes may be associated with a higher risk of liver disease progression, increased transmission rates, or resistance to specific antiviral drugs. Additionally, genotyping can help guide treatment decisions by identifying which antiviral medications are likely to be most effective against a particular genotype. In summary, Hepatitis B viral drug resistance and genotyping tests are essential tools in the management of Hepatitis B infection. These tests help healthcare providers tailor treatment plans to individual patients, ensuring the most effective and personalized care.